Reviva Pharmaceuticals Holdings Inc.
RVPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.53M
Close$
$0.39
22.2% downside
Current Fair Value
22.2% downsideOvervalued by 22.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.53 Million |
|---|---|
| Enterprise Value | $-19,745,860,466,708.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.48 |
| Beta | 0.49 |
| Outstanding Shares | 13,209,000 |
Return
| Return on Equity | -146.72% |
|---|---|
| Return on Assets | -105.54% |
| Return on Invested Capital | -150.04% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.48
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 5.08% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.10%▼ 52.33% |
|---|---|
| Total Invested | $3,414▼ 99.87% |
| Investors Holding | 4▼ 33.00% |
ESG Score
No data
About Reviva Pharmaceuticals Holdings Inc.
5 employeesReviva Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva's primary ...